About Aspargo Laboratories

About company

Aspargo Laboratories commercialize rights of an oral suspension spray formulation of erectile dysfunction medication Sildenafil citrate. Spray formulation offers convenient drug administration, flexible dose titration and accessibility for patients with dysphagia (trouble swallowing). Currently, it has approved for sale in 9 European countries and 8 Latin American countries, with pending approvals in Portugal, Mexico, Italy, Czech Republic, Slovak Republic, Greece, Australia and China. Applications for approval are planned for Croatia, France, Germany and Austria.